Metafora Biosystems

We are passionate about cell biology

and leverage our unique cell metabolism and AI-powered data analysis platforms
to shorten the time to critical insights and improve human health

Our products

We are experts in single-cell analysis, metabolism, and AI

Proper metabolism is key for cell fate and function in the body.

Our unique IVD and cell therapy reagents allow monitoring pf cellular fitness and metabolism.

We leverage our proprietary platform to decipher single cell metabolic programs. In addition, we help clinicians infer clinical outcomes of disease from our In vitro diagnostics, and improve optimization of cell therapy products.

METAflow is the only software
able to offer an “augmented intelligence” solution allowing users to get quick, objective and reproducible results.

A highly differentiated approach to modern flow- and mass-cytometry analysis, for use in research and clinical diagnostics.

Meet our team

A multidisciplinary team of Entrepreneurs, Biologists, Data Scientists, and expert Mathematicians
from 12 nationalities, based in Paris, France, and the USA

Our latest news

November 19, 2022

EIC Accelerator Funding awarded to drive innovation and next-level growth

September 21, 2022

Introducing METAflow our innovative AI cytometry data analysis platform at ESCCA 2022

February 2, 2022

Poster presentation on METAglut1™ our innovative IVD blood test at the meeting of SFNP 2022

January 15, 2020

New results on METAglut1™ validation study presented at the meeting of SFNP 2020

June 21, 2019

Proud Laureate of the PhD Paris Region Funding Initiative

March 22, 2019

Oral presentation on METAglut1™ our innovative IVD blood test at the meeting of SENP 2019

February 20, 2019

€1M Grant from Bpifrance’s Innovation Prize

January 16, 2019

Poster presentation on METAglut1™ our innovative IVD blood test at the meeting of SFNP 2019

June 22, 2018

Booth at the European Conference on Glut1 Deficiency 2018

June 11, 2018

€3.2M European Grant awarded: a major boost for the launch of our validation study

July 13, 2017

Attending the summit of the Glut1 Deficiency Foundation 2017 to talk about METAglut1™ our innovative IVD blood test

April 16, 2016

Exclusive Interview with BFM Business Radio: our participation in the BigBooster Program

February 10, 2016

Selected for the BigBooster Acceleration Program

Our achievements

February 2024
METAglut1™ obtains universal national coverage
in France as recommended by the
French National Authority for Health
(Haute Autorité de Santé, HAS)
July 2023
Showcase of early version of
METAflow for research
October 2022
Laureate of EIC (European Innovation Council) accelerator program to develop METAflow™
for clinical applications
June 2021
Partnership with Sebia to develop innovative IVDs (In Vitro Diagnositics)
for Hemato-Oncology
January 2019
Winner of the Innovation Prize from Bpifrance
to develop the METAbolism platform
for diagnostics in Oncology
June 2018
Laureate of H2020 Innovation Grant
to fund METAglut1™ 's validation study
March 2018
METAglut1™ obtains the Forfait Innovation
(fast track reimbursement program)
after its CE-Marking in 2017

Our awards

Our worldwide partnerships

At METAFORA, we are building an ecosystem to ensure that our solutions meet expectations.

Patient associations help us to deeply understand unmet needs, when leading medical researchers collaborate with us to develop and validate our solutions. We are grateful to many institutions for their continuous support and we are also working hard to extend our collaborations to make our solutions available for daily clinical practice.